TE_20420
Basic information Differential Expression Stage analysis Survival analysis Correlation analysisTE family | MER61A |
---|---|
TE superfamily | ERV1 |
TE class | LTR |
Gene | - |
Class | Intergenic |
Coding | Non-coding |
Tumor-specific score | 543.82 |
Counts of samples | TCGA_tumor:964; TCGA_normal:0; GTEx:1 |
TSS | chr9(+):31848660 |
Transcript isoforms
Transcript_ID | Gene | Class | Coding | ORF | Position |
---|---|---|---|---|---|
teRNA_20420.31 | - | Intergenic | Non-coding | Non-coding | chr9(+):31848661,31848907,31878547,31878567 |
teRNA_20420.32 | - | Intergenic | Non-coding | Non-coding | chr9(+):31848661,31848907,31924536,31924556 |
teRNA_20420.33 | - | Intergenic | Non-coding | Non-coding | chr9(+):31848661,31848907,31924536,31924639,31942991,31943011 |
teRNA_20420.34 | - | Intergenic | Non-coding | Non-coding | chr9(+):31848661,31848907,31924536,31924631,31959038,31959058 |
teRNA_20420.35 | - | Intergenic | Non-coding | Non-coding | chr9(+):31848661,31848907,31959038,31959119,31973015,31973035 |
teRNA_20420.36 | - | Intergenic | Non-coding | Non-coding | chr9(+):31848661,31848907,31959038,31959119,31973015,31973112,32112170,32112190 |
teRNA_20420.37 | - | Intergenic | Non-coding | Non-coding | chr9(+):31848661,31848907,31897610,31897630 |
teRNA_20420.38 | - | Intergenic | Non-coding | Non-coding | chr9(+):31848661,31848907,32085354,32085374 |
teRNA_20420.39 | - | Intergenic | Non-coding | Non-coding | chr9(+):31848661,31848907,32085354,32085376,32087312,32087332 |
teRNA_20420.40 | - | Intergenic | Non-coding | Non-coding | chr9(+):31848661,31848907,31854062,31854082 |
GTEx
The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.
TCGA
The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).
GTEx
The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.